Abstract
Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disease that represents a broad spectrum of morphologic features and clinical presentations. However, little is known about the impact of gender differences in heart failure (HF) development in non-obstructive HCM. We assessed clinical and echocardiographic parameters according to gender in patients with non-obstructive HCM and evaluated the impact of gender on HF presentation and cardiovascular (CV) outcomes in this population. We investigated 202 consecutive patients with non-obstructive HCM. Clinical parameters and conventional echocardiographic measurements including tissue Doppler measurements were evaluated and compared according to gender. Additionally, left ventricular (LV) deformation was assessed with global longitudinal strain (GLS) utilizing 2D speckle tracking software. Of the 202 patients (age = 63 ± 14 years, male: female = 141: 61), 51 patients (24.8%) presented with HF and female patients had HF more frequently (52.5% vs. 12.8%, P < 0.001). Females were older, had a higher prevalence of atrial fibrillation, had increased left atrial volume (LAV), and a higher ratio of early diastolic mitral inflow to early annular velocity (E/e′) than males (70 ± 12 years vs. 59 ± 14 years, P < 0.001 for age; 51.4 ± 19.3 mL/m2 vs. 40.0 \(\pm\) 13.4 mL/m2, P < 0.001 for indexed LAV; 17.2 \(\pm\) 6.0 vs. 13.0 \(\pm\) 4.3, P < 0.001 for E/e′). While LV maximal thickness and LV ejection fraction were comparable between men and women, GLS was decreased significantly in female patients (− 13.5 \(\pm\) 3.4% vs. − 15.6 \(\pm\) 4.0%, P = 0.001 for GLS). Even after adjusting for clinical factors, female was independently associated with HF presentation (Odd ratio 5.19, 95% CI 2.24–12.03, P < 0.001). During a median follow-up duration 34.0 months, 20 patients (9.9%) had HF hospitalization or CV death. In a multivariable analysis, female gender was associated with higher risk of the composite of HF hospitalization or CV death and HF hospitalization alone than male (Adjusted hazard ratio [HR] = 3.31, 95% CI 1.17–9.35, P = 0.024 for primary composite outcome of HF hospitalization or CV death; adjusted HR = 4.78, 95% CI 1.53–14.96, P = 0.007 for HF hospitalization). In patients with non-obstructive HCM, female patients presented with HF more frequently and showed a higher risk of CV events than male patients. LA volume, E/e′ and LV mechanics were different between the genders, suggesting that these might contribute to greater susceptibility to HF in women with HCM.
Similar content being viewed by others
References
Olivotto I, Maron MS, Adabag AS, Casey SA, Vargiu D, Link MS, Udelson JE, Cecchi F, Maron BJ (2005) Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol 46:480–487
Kubo T, Kitaoka H, Okawa M, Hirota T, Hayato K, Yamasaki N, Matsumura Y, Yabe T (2010) Gender-specific differences in the clinical features of hypertrophic cardiomyopathy in a community-based Japanese population: results from Kochi RYOMA study. J Cardiol 56:314–319
Terauchi Y, Kubo T, Baba Y, Hirota T, Tanioka K, Yamasaki N, Furuno T, Kitaoka H (2015) Gender differences in the clinical features of hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Cardiol 65:423–428
Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ (2003) Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348:295–303
Maron BJ, Rowin EJ, Maron MS, Braunwald E (2017) Nonobstructive hypertrophic cardiomyopathy out of the shadows: known from the beginning but largely ignored … until now. Am J Med 130:119–123
Maron MS, Rowin EJ, Olivotto I, Casey SA, Arretini A, Tomberli B, Garberich RF, Link MS, Chan RHM, Lesser JR, Maron BJ (2016) Contemporary natural history and management of nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 67:1399–1409
Hebl VB, Miranda WR, Ong KC, Hodge DO, Bos JM, Gentile F, Klarich KW, Nishimura RA, Ackerman MJ, Gersh BJ, Ommen SR, Geske JB (2016) The natural history of nonobstructive hypertrophic cardiomyopathy. Mayo Clin Proc 91:279–287
Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, Aylward P, Topol EJ, Califf RM (1999) Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med 341:226–232
Ghali JK, Krause-Steinrauf HJ, Adams KF, Khan SS, Rosenberg YD, Yancy CW, Young JB, Goldman S, Peberdy MA, Lindenfeld J (2003) Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol 42:2128–2134
Carroll JD, Carroll EP, Feldman T, Ward DM, Lang RM, McGaughey D, Karp RB (1992) Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 86:1099–1107
Tada H, Sticherling C, Chough SP, Baker RL, Wasmer K, Daoud EG, Oral H, Pelosi F Jr, Knight BP, Strickberger SA, Morady F (2001) Gender and age differences in induced atrial fibrillation. Am J Cardiol 88:436–438
Lampert R, McPherson CA, Clancy JF, Caulin-Glaser TL, Rosenfeld LE, Batsford WP (2004) Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators. J Am Coll Cardiol 43:2293–2299
Meyer S, van der Meer P, van Tintelen JP, van den Berg MP (2014) Sex differences in cardiomyopathies. Eur J Heart Fail 16:238–247
Houston BA, Stevens GR (2014) Hypertrophic cardiomyopathy: a review. Clin Med Insights Cardiol 8:53–65
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors Task Force, M, Document R, (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM (2017) 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol 70:776–803
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1–39 e14
Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinones M, Eae Ase (2009) Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 10:1–25
Olivotto I, Gistri R, Petrone P, Pedemonte E, Vargiu D, Cecchi F (2003) Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 41:315–321
Bos JM, Ommen SR, Ackerman MJ (2007) Genetics of hypertrophic cardiomyopathy: one, two, or more diseases? Curr Opin Cardiol 22:193–199
Nagueh SF, Bierig SM, Budoff MJ, Desai M, Dilsizian V, Eidem B, Goldstein SA, Hung J, Maron MS, Ommen SR, Woo A, American Society of E, American Society of Nuclear C, Society for Cardiovascular Magnetic R, Society of Cardiovascular Computed T (2011) American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 24:473–498
Dimitrow PP, Czarnecka D, Strojny JA, Kawecka-Jaszcz K, Dubiel JS (2001) Impact of gender on the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy. Int J Cardiol 77:43–48
Page SP, Kounas S, Syrris P, Christiansen M, Frank-Hansen R, Andersen PS, Elliott PM, McKenna WJ (2012) Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome. Circ Cardiovasc Genet 5:156–166
Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ (2001) Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 104:2517–2524
Mosca L, Ferris A, Fabunmi R, Robertson RM, American Heart A (2004) Tracking women's awareness of heart disease: an American Heart Association national study. Circulation 109:573–579
Mosca L, Jones WK, King KB, Ouyang P, Redberg RF, Hill MN, Dis AHAWH (2000) Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. Arch Fam Med 9:506–515
Arain FA, Kuniyoshi FH, Abdalrhim AD, Miller VM (2009) Sex/gender medicine. The biological basis for personalized care in cardiovascular medicine. Circ J 73:1774–1782
Malhotra A, Buttrick P, Scheuer J (1990) Effects of sex hormones on development of physiological and pathological cardiac hypertrophy in male and female rats. Am J Physiol 259:H866–871
Geske JB, Ong KC, Siontis KC, Hebl VB, Ackerman MJ, Hodge DO, Miller VM, Nishimura RA, Oh JK, Schaff HV, Gersh BJ, Ommen SR (2017) Women with hypertrophic cardiomyopathy have worse survival. Eur Heart J 38:3434–3440
Kerr CR, Humphries K (2005) Gender-related differences in atrial fibrillation. J Am Coll Cardiol 46:1307–1308
Nasermoaddeli A, Miura K, Matsumori A, Soyama Y, Morikawa Y, Kitabatake A, Inaba Y, Nakagawa H (2007) Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide study. Heart 93:711–715
Serri K, Reant P, Lafitte M, Berhouet M, Le Bouffos V, Roudaut R, Lafitte S (2006) Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. J Am Coll Cardiol 47:1175–1181
DeVore AD, McNulty S, Alenezi F, Ersboll M, Vader JM, Oh JK, Lin G, Redfield MM, Lewis G, Semigran MJ, Anstrom KJ, Hernandez AF, Velazquez EJ (2017) Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial. Eur J Heart Fail 19:893–900
Kraigher-Krainer E, Shah AM, Gupta DK, Santos A, Claggett B, Pieske B, Zile MR, Voors AA, Lefkowitz MP, Packer M, McMurray JJ, Solomon SD, Investigators P (2014) Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. J Am Coll Cardiol 63:447–456
Abozguia K, Nallur-Shivu G, Phan TT, Ahmed I, Kalra R, Weaver RA, McKenna WJ, Sanderson JE, Elliott P, Frenneaux MP (2010) Left ventricular strain and untwist in hypertrophic cardiomyopathy: relation to exercise capacity. Am Heart J 159:825–832
Tadic M, Cuspidi C, Plein S, Belyavskiy E, Heinzel F, Galderisi M (2019) Sex and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Clinical Studies. J Clin Med 8:792
Okura H, Takada Y, Yamabe A, Kubo T, Asawa K, Ozaki T, Yamagishi H, Toda I, Yoshiyama M, Yoshikawa J, Yoshida K (2009) Age- and gender-specific changes in the left ventricular relaxation: a Doppler echocardiographic study in healthy individuals. Circ Cardiovasc Imaging 2:41–46
Kim EK, Lee SC, Hwang JW, Chang SA, Park SJ, On YK, Park KM, Choe YH, Kim SM, Park SW, Oh JK (2016) Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients. Eur Heart J Cardiovasc Imaging 17:678–686
Acknowledgement
This work was supported by Inha University Hospital Grant
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jang, JH., Shin, SH., Beak, Y.S. et al. Impact of gender on heart failure presentation in non-obstructive hypertrophic cardiomyopathy. Heart Vessels 35, 214–222 (2020). https://doi.org/10.1007/s00380-019-01492-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-019-01492-0